ResMed Inc. (RMD)
NYSE
Closed
Oct 8, 2026
Day's Range
223.0452 wk Range
180.27Overview - RMD - ResMed Inc.
Key Statistics
Valuation
Enterprise Value
30.93B
P/E (Trailing)
‪20.96‬
P/E (Forward)
‪16.54‬
PEG Ratio
‪9.05‬
Price / Sales (TTM)
‪5.58‬
Price / Book
‪4.79‬
EV / EBITDA
‪14.75‬
Profitability
Gross Margin
‪58.84%‬
Profit Margin
‪26.94%‬
Operating Margin
‪30.85%‬
Return on Assets
‪14.00%‬
Return on Equity
‪24.26%‬
Ownership
Shares Outstanding
144.23M
Float
143.36M
Short % of Shares Outstanding
‪11.35%‬
Held by Insiders
‪0.49%‬
Held by Institutions
‪71.16%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪222.72‬
200-Day Avg
‪225.88‬
Dividends
Payout Ratio
‪23.01%‬
Frequency
Quarterly
Analyst Consensus
20 analysts
Average price target
‪$ 245.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RMD - ResMed Inc.
Peers - RMD - ResMed Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - RMD - ResMed Inc.
About
ResMed Inc. is a global medical technology and digital health company focused on sleep health, respiratory care, and out-of-hospital care. ResMed develops and markets cloud-connected medical devices, including positive airway pressure systems, masks, home ventilators, and related accessories used to diagnose and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
